Instylla Completes Enrollment of Landmark Hypervascular Tumor Pivotal Study Clinical investigators achieve significant milestone by enrolling 150 patients with hypervascular tumors in pivotal randomized study. BEDFORD, Mass., – May Read More »
Instylla Announces Completion of $30MM EQUITY Financing Secured financing advances Instylla’s clinical trials and commercialization readiness BEDFORD, Mass., – August 15, 2023 – Instylla, Inc., a privately Read More »
Instylla Announces Completion of Series B Financing Financing to see Instylla through US Pivotal and other clinical trials BEDFORD, Mass., Oct. 14, 2020 /PRNewswire/ — Instylla, Inc., a privately held Read More »